FDA.reportPublic FDA data

treprostinil 2.5 MG 12HR Extended Release Oral Tablet

RxCUI
1488678
RxNorm name
treprostinil 2.5 MG 12HR Extended Release Oral Tablet
Display name
treprostinil 2.5 MG 12HR Extended Release Oral Tablet
Full name
treprostinil 2.5 MG 12HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OrenitramTREPROSTINILUnited Therapeutics Corporation8ed2003a-c801-411e-831e-d06079bb0d7c2024-11-20Warnings, Adverse reactionsExact identifier
rxcui: 1488678

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8ed2003a-c801-411e-831e-d06079bb0d7ctreprostinil 2.5 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR treprostinil 2.5 MG Extended Release Oral Tablet [SCD] · treprostinil 2.5 MG (as treprostinil diethanolamine) 12 HR Extended Release Oral Tablet [SY] · treprostinil 2.5 MG (as treprostinil diolamine 3.17 MG) 12 HR Extended Release Oral Tablet [SY]424These highlights do not include all the information needed to use ORENITRAM safely and effectively. See Full Prescribing Information for ORENITRAM. ORENITRAM ® (treprostinil) extended-release tablets, for oral use Initial U.S. Approval: 200220241120